Innate Pharma SA, which develops drugs that target the innate immune system, reported that its revenues rose 68.6% to €14.3 million in 2007 from €8.5 million a year earlier while its net loss for 2007 widened to €8.9 million from €6 million. ---Subscribe to MedNous to access this article--- Company News
